Bringing the Oncology Community Together

Hematologic Cancer

OncLive TV - A Network of Your Peers

Dr. Hamlin on Integrating Brentuximab Vedotin

Dr. Berenson on Zometa as the Gold Standard for Myeloma

Dr. Hamlin on Brentuximab Vedotin Pharmacology

Dr. Zimran Discusses Gaucher Disease Biomarkers

Dr. Weinreb on the Different Roles in a Gaucher Diagnosis

>>> More Hematologic Cancer Videos

Novel Therapeutics Have Revolutionized Multiple Myeloma Treatment

Novel therapeutics, including thalidomide, lenalidomide (Revlimid), and bortezomib (Velcade), have revolutionized the treatment of multiple myeloma.

Oncology & Biotech News > Conference Highlights

Treatment of Large Cell Lymphoma: R-CHOP and Beyond

The treatment of diffuse large B-cell lymphoma continues to evolve, as researchers seek to improve upon the current standard of care.

Oncology & Biotech News > Conference Highlights

Taking Comfort

Much has been made of the difficulties companies, investigators, and patient advocates have in providing access to novel therapies.

Oncology & Biotech News > From The Editor

Noted Researcher Sees ERT as Remarkable Beginning

The treatment of Gaucher disease is poised to enter a new era as a result of advances in the understanding of the cellular pathways at work in the disorder.

Conferences > Updates From the ICHG/ASHG 61st Annual Meeting

Nonmyeloablative Conditioning Before Cell Transplantation Shows Potential in Older Patients With Hematologic Malignancies

Older patients with advanced hematologic malignancies who receive a minimally toxic nonmyeloablative regimen before allogeneic HCT have favorable OS and PFS rates.

Onc Nurse > Feature Story